CorMedix Inc. (CRMD) NASDAQ

8.17

-0.28(-3.31%)

Updated at June 02 04:00PM

Currency In USD

CorMedix Inc.

Address

300 Connell Drive

Berkeley Heights, NJ 07922

United States of America (the)

Phone

908 517 9500

Website

https://www.cormedix.com

Sector

Healthcare

Industry

Biotechnology

Employees

First IPO Date

May 13, 2010

Key Executives

Name	Title	Pay	Year Born
Joseph Todisco	CEO & Chairman of the Board of Directors	1.61M	1976
Michael Seckler	Executive Vice President & Chief Commercial Officer	561,571	1966
Susan Blum	Executive Vice President & Chief Financial Officer	634,855	1973
Matthew T. David	EVP & Chief Business Officer	634,855	1978
Elizabeth Hurlburt	Executive Vice President, Chief Operating Officer & Chief Integration Officer	959,370	1979
Kaufman Beth Zelnick	EVP, Chief Legal and Compliance Officer & Corporate Secretary	981,592	1961
Beth Steinbrenner	SVP & Chief Human Resource Officer	0	N/A
Peter Sullivan BCOP	Senior Vice President of Market Access	0	N/A
Jared L. Crandon	Executive Director of Clinical Portfolio Management	0	N/A
Donna Ucci	Senior Vice President & Head of Global Quality	0	N/A
Tushar Mukherjee	Senior Vice President & Head of Technical Operations	0	N/A

Description

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings, such as hemodialysis, total parenteral nutrition, and oncology. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.